NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $622,365 | +2.0% | 6,110 | +1.1% | 0.06% | +5.2% |
| Q2 2023 | $609,900 | +8.3% | 6,044 | -1.3% | 0.06% | 0.0% |
| Q1 2023 | $563,408 | +95070.3% | 6,124 | -6.2% | 0.06% | -14.7% |
| Q4 2022 | $592 | -99.9% | 6,529 | -2.2% | 0.07% | +11.5% |
| Q3 2022 | $507,000 | -8.8% | 6,675 | +1.5% | 0.06% | 0.0% |
| Q2 2022 | $556,000 | -5.3% | 6,579 | -1.7% | 0.06% | +7.0% |
| Q1 2022 | $587,000 | +0.2% | 6,694 | 0.0% | 0.06% | +1.8% |
| Q4 2021 | $586,000 | 0.0% | 6,694 | -6.6% | 0.06% | -8.2% |
| Q3 2021 | $586,000 | -26.9% | 7,168 | -18.4% | 0.06% | -28.2% |
| Q2 2021 | $802,000 | +14.7% | 8,789 | +3.7% | 0.08% | -34.6% |
| Q1 2021 | $699,000 | +12.6% | 8,475 | +28.9% | 0.13% | +58.5% |
| Q4 2020 | $621,000 | +2.3% | 6,575 | -5.8% | 0.08% | -9.9% |
| Q3 2020 | $607,000 | -16.3% | 6,979 | -16.0% | 0.09% | -19.5% |
| Q2 2020 | $725,000 | -77.8% | 8,306 | -77.9% | 0.11% | -58.6% |
| Q1 2020 | $3,268,000 | +83.0% | 37,602 | +99.3% | 0.27% | -1.1% |
| Q4 2019 | $1,786,000 | +9.3% | 18,866 | +0.3% | 0.28% | +1.1% |
| Q3 2019 | $1,634,000 | -84.5% | 18,801 | -83.7% | 0.27% | -85.0% |
| Q2 2019 | $10,523,000 | -4.9% | 115,243 | +0.1% | 1.82% | -10.7% |
| Q1 2019 | $11,068,000 | +14.5% | 115,122 | +2.2% | 2.04% | +2.9% |
| Q4 2018 | $9,665,000 | -2.8% | 112,625 | -2.4% | 1.98% | +24.4% |
| Q3 2018 | $9,943,000 | +12.5% | 115,397 | -1.3% | 1.60% | +4.8% |
| Q2 2018 | $8,835,000 | -5.7% | 116,950 | +1.0% | 1.52% | -8.6% |
| Q1 2018 | $9,366,000 | -0.1% | 115,844 | +3.7% | 1.66% | -5.3% |
| Q4 2017 | $9,380,000 | -2.5% | 111,727 | -0.3% | 1.76% | +10.3% |
| Q3 2017 | $9,616,000 | +4.5% | 112,011 | +1.6% | 1.60% | -5.3% |
| Q2 2017 | $9,206,000 | +31.9% | 110,289 | +17.3% | 1.68% | +21.2% |
| Q1 2017 | $6,982,000 | +67.6% | 94,014 | +86.2% | 1.39% | +26.6% |
| Q2 2016 | $4,167,000 | +16568.0% | 50,498 | +20099.2% | 1.10% | +12088.9% |
| Q1 2015 | $25,000 | -99.4% | 250 | -99.5% | 0.01% | -99.5% |
| Q1 2014 | $4,524,000 | +4.8% | 53,212 | -0.9% | 1.86% | -2.2% |
| Q4 2013 | $4,318,000 | +16.6% | 53,722 | +11.3% | 1.90% | -1.2% |
| Q3 2013 | $3,702,000 | -44.5% | 48,262 | -48.9% | 1.93% | -56.1% |
| Q2 2013 | $6,673,000 | – | 94,380 | – | 4.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |